Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-10-24FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved an original application for Colestipol hydrochloride, a bile acid sequestrant used to treat hyperlipidemia and hypercholesterol…
-
FDA approval · 2006-10-23FDA Approved: PRAVASTATIN SODIUM — Original Application (Quallent)
FDA approves the original application (ANDA) for Pravastatin Sodium (generic pravastatin) from Quallent, establishing a generic statin produ…
-
FDA approval · 2006-10-23FDA Approved: PRAVASTATIN SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories Limited pravastatin sodium under an Original Application (ANDA). This marks a new generic product appr…
-
FDA approval · 2006-10-03FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC. This document confirms the app…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics [Phase 4]
A Phase 4 clinical trial evaluating integration of family medicine and pharmacy to advance primary care therapeutics has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2006-08-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin from Prasco Laboratories, resulting in…
-
CLINICAL_TRIALS trial_result · 2006-08-17Clinical Trial Update: Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements [NA]
A completed clinical trial comparing statin therapy against therapeutic lifestyle changes and supplements for hyperlipidemia.
-
CLINICAL_TRIALS research · 2006-08-15Clinical Trial Update: Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
An observational study sponsored by NIAID examining changes in fat distribution and blood metabolites in adults with HIV infection, includin…
-
FDA approval · 2006-07-27FDA Approved: GEMFIBROZIL — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approved the original application for a generic Gemfibrozil by Exelan Pharmaceuticals, enabling a generic version of Gemfibrozil to be m…
-
FDA approval · 2006-07-03FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC, resulting in updated labeling.…
-
CLINICAL_TRIALS trial_result · 2006-06-28Clinical Trial Update: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Phase 4]
Phase 4 efficacy trial comparing Extended-Release Niacin/Lovastatin to usual care in patients with lipid disorders. The study has completed.
-
FDA approval · 2006-06-23FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2006-06-09Clinical Trial Update: Pravastatin for Hyperlipidaemia in HIV. [Phase 4]
A Phase 4 clinical trial evaluating pravastatin for hyperlipidemia in HIV-infected individuals has completed.
-
FDA approval · 2006-05-23FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.